Impax Laboratories is now part of
Amneal Pharmaceuticals
On May 4, 2018, Amneal Pharmaceuticals and Impax Laboratories combined under one corporate parent,
and now operate as Amneal Pharmaceuticals. Amneal Pharmaceuticals, Inc. is a publicly listed company
traded on the New York Stock Exchange (NYSE: AMRX).
For Product Questions, Comments and Returns:
Amneal, Impax and/or Gemini Laboratories Products: Report adverse events, product quality complaints
and for medical information inquiries in the United States.
Call: (877) 835-5472, option 1 or email: DrugSafety@amneal.com